Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis

Xuehan Chen(Dalian Medical University), Tie Zhang(Hebei Agricultural University), Yuanying Zeng(Suzhou Municipal Hospital), Qi Wang(Hebei Medical University), Xiaoge Wang(Guangzhou University of Chinese Medicine), Peng Lin(Soochow University), Biyin Cao(Soochow University), Xinliang Mao(Guangzhou Medical University), Yujia Xu(Jiangnan University), Zu-bin Zhang(Soochow University)
Acta Pharmacologica Sinica
June 13, 2019
Cited by 41


Related Papers